TCBPY (TC BioPharm (Holdings)) Other Current Receivables : $1.67 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Other Current Receivables?

TC BioPharm (Holdings)'s Other Current Receivables for the quarter that ended in Jun. 2024 was $1.67 Mil.

TC BioPharm (Holdings)'s quarterly Other Current Receivables increased from Dec. 2023 ($1.56 Mil) to Mar. 2024 ($1.62 Mil) and increased from Mar. 2024 ($1.62 Mil) to Jun. 2024 ($1.67 Mil).

TC BioPharm (Holdings)'s annual Other Current Receivables increased from Dec. 2021 ($1.97 Mil) to Dec. 2022 ($2.20 Mil) but then declined from Dec. 2022 ($2.20 Mil) to Dec. 2023 ($1.56 Mil).

TC BioPharm (Holdings) Other Current Receivables Historical Data

The historical data trend for TC BioPharm (Holdings)'s Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Other Current Receivables Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

3.82

1.66

1.97

2.20

1.56

TC BioPharm (Holdings) Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Other Current Receivables	Get a 7-Day Free Trial						-	3.20	1.56	1.62	1.67

TC BioPharm (Holdings) Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

TC BioPharm (Holdings) Other Current Receivables Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (OTCPK:TCBPY) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD